Skip to main content
ATOSSA THERAPEUTICS, INC. logo

ATOSSA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ATOS ISIN · US04962H5063 US Manufacturing
Open in API
Filings indexed 622 across all filing types
Latest filing 2013-01-10 Director's Dealing
Country US United States of America
Listing US ATOS

About ATOSSA THERAPEUTICS, INC.

https://atossatherapeutics.com/

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative medicines for areas of significant unmet medical need, with a primary focus on oncology. The company is dedicated to addressing the full continuum of breast cancer care. Its lead program is centered on (Z)-endoxifen, a proprietary and potent selective estrogen receptor modulator (SERM). Atossa is advancing (Z)-endoxifen through clinical development for multiple breast cancer indications, including metastatic disease, aiming to provide a therapeutic with a potentially improved efficacy and tolerability profile.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2013-01-10 English
PRIMARY DOCUMENT
Director's Dealing
2013-01-09 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the appointment of a new Chief Financial Officer and General Counsel, including biographical information, compensation, stock options, and termination of the previous interim CFO. There are no financial statements or earnings data included. The key focus is on management changes, which aligns with announcements about changes in the company's board of directors or senior management. Therefore, this document fits the category of Board/Management Information (MANG). The document length is sufficient and contains detailed information about the management change, not just a brief notice or announcement of a report publication, so it is not RPA or RNS. Hence, the classification is MANG with high confidence.
2013-01-04 English
REGISTRATION STATEMENT
Capital/Financing Update Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC. Form S-8 is used for registering securities to be offered under employee benefit plans, such as stock option plans. The document includes details about the securities to be registered, the plan under which they are offered, indemnification provisions, and undertakings related to the registration. It is not an annual report, earnings release, or any other financial report but a registration statement related to capital raising through employee stock plans. This fits the category of Capital/Financing Update (CAP) as it relates to registration of securities for issuance under an incentive plan.
2012-12-21 English
10-Q
Interim / Quarterly Report Q3 2012
2012-12-21 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The content includes an amendment to the company's bylaws and a reference to a press release reporting earnings results for the third quarter of 2012. The document does not contain the full earnings report or detailed financial statements but rather announces the earnings release and a governance change (amendment to bylaws). The document length is 3557 characters, which is relatively short and consistent with an announcement rather than a full report. The primary content is an announcement of a governance amendment and a reference to an earnings press release, not the earnings release itself. Therefore, the best classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes current reports like Form 8-K that announce events without providing full reports.
2012-12-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.